Association of psychological disorders with 30-day readmission rates in patients with COPD

Chest

Volumn 149, Issue 4, 2016, Pages 905-915

  Singh, Gurinder ^a   Zhang, Wei ^a   Kuo, Yong Fang ^b   Sharma, Gulshan ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Anxiety; COPD; Depression; Medicare; Readmission

Indexed keywords

ALCOHOL;

AGED; ALCOHOL ABUSE; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; ALCOHOLISM; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; DISEASE COURSE; MENTAL DISORDERS; MULTIVARIATE ANALYSIS; ODDS RATIO; PSYCHOLOGY; PSYCHOTIC DISORDERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALCOHOLISM; ANXIETY; ANXIETY DISORDERS; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICARE; MENTAL DISORDERS; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT READMISSION; PSYCHOTIC DISORDERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL CLASS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84964444641     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-0449     Document Type: Article

References (73)

1. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205-1211.
2. Ng T-P, Niti M, Tan W-C, Cao Z, Ong K-C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60-67.
3. Fan VS, Ramsey SD, Giardino ND, et al; National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167(21):2345-2353.
4. Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol. 2000;10(02): 193-202.
5. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65-70.
6. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209-1221.
7. Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med. 2009;71(6):667-674.
8. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293-299.
9. Xu W, Collet J-P, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9): 913-920.
10. Jennings JH, Digiovine B, Obeid D, Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009; 187(2):128-135.
11. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766-777.
12. Qian J, Simoni-Wastila L, Langenberg P, et al. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2013;61(5):754-761.
13. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418-1428.
14. Elixhauser A, Steiner C. Readmissions to US hospitals by diagnosis, 2010. http:// www.hcup-us.ahrq.gov/reports/statbriefs/ sb153.pdf. Accessed January 23, 2015.
15. Hurst JR, Vestbo J, Anzueto A, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-1138.
16. Shah T, Churpek MM, Coca Perraillon M, Konetzka RT. Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion. Chest. 2015;147(5): 1219-1226.
17. Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551-559.
18. Sharif R, Parekh TM, Pierson KS, Kuo Y-F, Sharma G. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):685-694.
19. Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87-93.
20. Sharma G, Kuo Y-F, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010;170(18):1664-1670.
21. Hines AL, Barrett ML, Jiang HJ, Steiner CA. Conditions with the largest number of adult hospital readmissions by payer, 2011. http://www.hcup-us.ahrq.gov/reports/ statbriefs/sb172-Conditions-Readmissions-Payer.pdf. Accessed January 24, 2015.
22. Readmission reduction program. Centers for Medicare and Medicaid Services website. http://www.cms.gov/Medicare/ medicare-fee-for-service-payment/ acuteinpatientPPS/readmissionsreduction-program.html. Revised August 4, 2014. Accessed September 19, 2014.
23. ResDAC. Research Data Assistance Center; 2013. http://www.resdac.org/ cms-data. Accessed April 19, 2015.
24. Medicare data documentation. Centers for Medicare & Medicaid Services website. http://www.resdac.org/cms-data/variables/ Hospital-Readmissions. 2013. Accessed January 24, 2015.
25. Krumholz HM, Normand S, Keenan P, et al. Hospital 30-day acute myocardial infarction readmission measure: methodology. A report prepared for the Centers for Medicare & Medicaid Services. 2008. https://medicine.yale.edu/ core/projects/quality-measurement/ publications-archive.aspx. Accessed April 19, 2015.
26. Medicaid eligibility for adults. Kaiser Family Foundation website. http://kff.org/ medicaid/fact-sheet/medicaid-eligibilityfor-adults-as-of-january-1-2014/. 2015. Accessed April 19, 2015.
27. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
28. Elixhauser Comorbidity Index. Manitoba Centre for Health Policy website. http://mchp-appserv.cpe.umanitoba.ca/view Definition.php?definitionID=102624. 2009. Accessed April 18, 2015.
29. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43(11):1130-1139.
30. Natarajan S, Lipsitz S, Parzen M, Lipshultz S. A measure of partial association for generalized estimating equations. Stat Model. 2007;7(2):175-190.
31. Wittayanukorn S, Qian J, Hansen RA. Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010. Gen Hosp Psychiatry. 2014;36(3):330-336.
32. Markkula N, Suvisaari J, Saarni SI, et al. Prevalence and correlates of major depressive disorder and dysthymia in an eleven-year follow-up: results from the Finnish Health 2011 Survey. J Affect Disord. 2015;173:73-80.
33. Coventry PA, Gemmell I, Todd CJ. Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study. BMC Pulm Med. 2011;11(1):49.
34. Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011;65(1):26-34.
35. Abrams TE, Vaughan-Sarrazin M, Van der Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52(5):441-449.
36. Hoth KF, Ford DW, Sandhaus RA, Strange C, Wamboldt FS, Holm KE. Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPD. COPD. 2012;9(4):417-425.
37. Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012;185(9): 918-923.
38. ten HM, Vollebergh W, Bijl R, Ormel J. Combined effect of mental disorder and low social support on care service use for mental health problems in the Dutch general population. Psychol Med. 2002; 32(2):311-323.
39. Almagro P, Soriano JB, Cabrera FJ, et al; Working Group on COPD, Spanish Society of Internal Medicine. Shortand medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014;145(5): 972-980.
40. Baillargeon J, Wang Y, Kuo Y-F, Holmes HM, Sharma G. Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. Am J Med. 2013;126(7):607-614.
41. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132(6):1748-1755.
42. Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5): 858-866.
43. Vögele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med. 2008;102(5):764-773.
44. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993;113(3):472-486.
45. Irwin M. Immune Correlates of Depression. Cytokines, Stress, and Depression. New York, NY: Springer; 1999:1-24.
46. Cohen S, Tyrrell DA, Smith AP. Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol. 1993;64(1): 131-140.
47. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134(4-suppl):43S-56S.
48. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
49. Almeida OP, Pfaff JJ. Depression and smoking amongst older general practice patients. J Affect Disord. 2005;86(2-3): 317-321.
50. Lou P, Chen P, Zhang P, et al. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care. 2014;59(1):54-61.
51. Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD, Group NR; Nett Research Group. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105-116.
52. Moore MC, Zebb BJ. The catastrophic misinterpretation of physiological distress. Behav Res Ther. 1999;37(11):1105-1118.
53. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med. 2000;161(2 pt 1):414-419.
54. Greene CC, Bradley KA, Bryson CL, et al. The association between alcohol consumption and risk of COPD exacerbation in a veteran population. Chest. 2008;134(4):761-767.
55. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33(2): 190-201.
56. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001;16(5):451-454.
57. Usmani Z, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(11):CD008483.
58. Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch RS. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry. 2006;14(5):466-475.
59. von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011;140(3):730-736.
60. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res. 2007;63(5):551-565.
61. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;10(10): CD005305.
62. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84(8):1154-1157.
63. Harris D, Hayter M, Allender S. Improving the uptake of pulmonary rehabilitation in patients with COPD: qualitative study of experiences and attitudes. Br J Gen Pract. 2008;58(555): 703-710.
64. Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309(4):342-343.
65. Hansen LO, Greenwald JL, Budnitz T, et al. Project BOOST: effectiveness of a multihospital effort to reduce rehospitalization. J Hosp Med. 2013;8(8): 421-427.
66. van Walraven C, Dhalla IA, Bell C, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010;182(6): 551-557.
67. Au AG, McAlister FA, Bakal JA, Ezekowitz J, Kaul P, van Walraven C. Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization. Am Heart J. 2012;164(3): 365-372.
68. Prieto-Centurion V, Markos MA, Ramey NI, et al. Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. Ann Am Thorac Soc. 2014;11(3):417-424.
69. Stein BD, Bautista A, Schumock GT, et al. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2012;141(1):87-93.
70. Townsend L, Walkup JT, Crystal S, Olfson M. A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidemiol Drug Saf. 2012;21(suppl 1):163-173.
71. Wells KB, Hays RD, Burnam MA, Rogers W, Greenfield S, Ware JE Jr. Detection of depressive disorder for patients receiving prepaid or fee-forservice care. Results from the Medical Outcomes Study. JAMA. 1989;262(23): 3298-3302.
72. Larkin GL, Claassen CA, Emond JA, Pelletier AJ, Camargo CA. Trends in U.S. emergency department visits for mental health conditions, 1992 to 2001. Psychiatr Serv. 2005;56(6):671-677.
73. Reeves WC, Strine TW, Pratt LA, et al; Centers for Disease Control and Prevention (CDC). Mental illness surveillance among adults in the United States. MMWR Surveill Summ. 2011;60(suppl 3):1-29.